higher earnings growth driven by continued share and efficiency gains. We believe that Medical-Surgical Products and Services should grow its revenues in the mid-single digits, but grow its net earnings at least 20% as it continues to incr ease its mix of Best Value Products as a percent of total sales and benefit fr om investment-driven efficien- cies, strong cash flows and tax initiatives. Phar maceutical Technologies and Services should grow its top line in the mid- to high teens and its ear nings in excess of 20%  as higher margin pharmaceutical products comprise a greater portion of this segment’s product mix. Finally, Automation and Information Services should grow its top line in excess of 20% annually and its ear nings at a faster rate due to new pr oduct introduc- tions, improvements in business mix and operating ef ficiencies. Kane – Our annual cash flow has continued to str engthen. In fiscal 2000, Cardinal’s operating cash flow was a r ecord $638 million. We expect operating cash flow to increase further in fiscal 2001 with a goal of appr oximately $700 million. We used our strong cash flow in 2000 to invest for our futur e – we spent more than $300 million  on capital expenditures and $67 million for acquisitions. In addition, we invested  $303 million to repurchase shares of Cardinal common stock. We intend to continue  to reinvest our strong cash flow to support our future growth, focusing on those opportu- nities that we believe will generate the best long-ter m returns for our shareholders. Kane – Cardinal has many products and services that are market leaders in their  own right, but even more appealing when combined with other company of ferings.  We have established two corporate sales teams inter nally – one to support the needs  of pharmaceutical and biotechnology companies, and the other, healthcare providers. For pharmaceutical companies, we efficiently provide integrated drug delivery, manu- facturing, packaging, distribution, and sales and marketing ser vices that can improve  a product’s effectiveness, extend its life cycle, r educe production cost and speed  time to market. These services will be showcased in Car dinal’s 265,000 square foot  Product Development Center currently being constructed in New Jersey. For healthcare providers, we offer the broadest array of pharmaceutical, medical-surgical and lab prod- ucts available anywhere, complemented by additional services including repackaging, automated dispensing, information, and management and consulting ser vices to help customers improve their utilization of healthcare products and improve overall quality of patient care. For Cardinal, our ability to provide such a broad range of products and services strengthens our relationships with healthcare providers and manufacturers, making us a more important, longer-term partner. 7 Cardinal Health, Inc. Annual Report 2000 Q: Cash flow has been incr easing at Cardinal in recent years. What are the  company’s priorities for investing these funds? Q: Cardinal has mentioned that many of its ser vices are complementary.  How do Cardinal’s businesses work together? Why is this impor tant? Q: Can you talk about Car dinal’s Internet strategy? What are the company’s  goals for e-commerce? Walter – E-commerce is not new to Car dinal. For many years now, more than 90% of our transactions with customers and suppliers have been conducted electr onically. During 2000, we took a significant step for ward by rolling out a two-pronged Internet strategy that will enable Cardinal and its customers to benefit fr om improved efficiency and cus- tomer service. The first step was the establishment of car dinal.com, one of the largest online catalogs in healthcare with more than half a million phar maceutical, medical- surgical and laboratory products available over the Internet. Cardinal.com also enables our customers to benefit from access to the same technologies and infor mation that Cardinal uses for procurement, fulfillment and customer support. In addition, we  established a commercially neutral healthcare information exchange along with three other healthcare companies representing combined revenues of about $70 billion. This exchange is focused on streamlining the processes involved in identifying, purchasing and distributing pharmaceutical products, medical-surgical products, devices and other laboratory products and services. These efforts provide our customers with convenient, comprehensive, online access to healthcare products and services 24 hours a day.